Correlation Between Zenas BioPharma, and Revelation Biosciences
Can any of the company-specific risk be diversified away by investing in both Zenas BioPharma, and Revelation Biosciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zenas BioPharma, and Revelation Biosciences into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zenas BioPharma, Common and Revelation Biosciences, you can compare the effects of market volatilities on Zenas BioPharma, and Revelation Biosciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zenas BioPharma, with a short position of Revelation Biosciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zenas BioPharma, and Revelation Biosciences.
Diversification Opportunities for Zenas BioPharma, and Revelation Biosciences
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Zenas and Revelation is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Zenas BioPharma, Common and Revelation Biosciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Revelation Biosciences and Zenas BioPharma, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zenas BioPharma, Common are associated (or correlated) with Revelation Biosciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Revelation Biosciences has no effect on the direction of Zenas BioPharma, i.e., Zenas BioPharma, and Revelation Biosciences go up and down completely randomly.
Pair Corralation between Zenas BioPharma, and Revelation Biosciences
Given the investment horizon of 90 days Zenas BioPharma, Common is expected to generate 1.46 times more return on investment than Revelation Biosciences. However, Zenas BioPharma, is 1.46 times more volatile than Revelation Biosciences. It trades about 0.18 of its potential returns per unit of risk. Revelation Biosciences is currently generating about -0.29 per unit of risk. If you would invest 1,728 in Zenas BioPharma, Common on August 18, 2025 and sell it today you would earn a total of 1,772 from holding Zenas BioPharma, Common or generate 102.55% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Zenas BioPharma, Common vs. Revelation Biosciences
Performance |
| Timeline |
| Zenas BioPharma, Common |
| Revelation Biosciences |
Zenas BioPharma, and Revelation Biosciences Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Zenas BioPharma, and Revelation Biosciences
The main advantage of trading using opposite Zenas BioPharma, and Revelation Biosciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zenas BioPharma, position performs unexpectedly, Revelation Biosciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Revelation Biosciences will offset losses from the drop in Revelation Biosciences' long position.| Zenas BioPharma, vs. Upstream Bio, | Zenas BioPharma, vs. Intellia Therapeutics | Zenas BioPharma, vs. Syndax Pharmaceuticals | Zenas BioPharma, vs. Wave Life Sciences |
| Revelation Biosciences vs. Scisparc | Revelation Biosciences vs. Onconetix | Revelation Biosciences vs. Indaptus Therapeutics | Revelation Biosciences vs. GT Biopharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities |